Detalhe da pesquisa
1.
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Eur J Nucl Med Mol Imaging
; 49(1): 371-384, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837843
2.
Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Dis Colon Rectum
; 62(2): 163-170, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30451764
3.
Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer.
Br Med Bull
; 128(1): 37-48, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30272121
4.
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Eur J Nucl Med Mol Imaging
; 49(2): 786-787, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894284
5.
Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
Radiology
; 271(1): 143-52, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24475824
6.
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
Eur J Nucl Med Mol Imaging
; 41(2): 337-42, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23942907
7.
PET/MRI: a new technology in the field of molecular imaging.
Br Med Bull
; 108: 159-71, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24227824
8.
68 Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor.
Clin Nucl Med
; 48(4): e184-e185, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727873
9.
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.
J Urol
; 188(5): 1732-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23017866
10.
Diffusion-weighted magnetic resonance imaging of the prostate: improved robustness with stretched exponential modeling.
J Comput Assist Tomogr
; 36(6): 695-703, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23192207
11.
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.
Nat Rev Urol
; 19(8): 475-493, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789204
12.
Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.
BJU Int
; 108(11): 1716-22, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21631696
13.
Imaging assessment of tumor response: past, present and future.
Future Oncol
; 7(5): 669-77, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21568682
14.
Pitfalls on PET/MRI.
Semin Nucl Med
; 51(5): 529-539, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34020770
15.
A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
J Nucl Med
; 2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741648
16.
Texture Analysis of Fractional Water Content Images Acquired during PET/MRI: Initial Evidence for an Association with Total Lesion Glycolysis, Survival and Gene Mutation Profile in Primary Colorectal Cancer.
Cancers (Basel)
; 13(11)2021 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34072712
17.
Tracheomegaly: a complication of fetal endoscopic tracheal occlusion in the treatment of congenital diaphragmatic hernia.
Pediatr Radiol
; 40(5): 674-80, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19894042
18.
Imaging of Prostate Cancer Recurrence in the Vas Deferens With 68Ga-PSMA PET/CT.
Clin Nucl Med
; 45(1): 49-51, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31789910
19.
Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial.
Int J Radiat Oncol Biol Phys
; 107(2): 316-324, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068113
20.
68Ga-Prostate-Specific Membrane Antigen PET/CT: Incidental Finding of a Liposarcoma.
Clin Nucl Med
; 44(2): e90-e92, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30608915